Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations and Comprehensive Loss

v3.24.3
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Revenue        
Revenue $ 22,549 $ 21,260 $ 71,723 $ 58,984
Costs and expenses        
Selling, general and administrative 17,961 17,572 54,991 55,289
Research and development 43 133 785 525
Depreciation and amortization 11,125 11,304 33,586 32,735
Operating loss (13,230) (14,516) (38,204) (51,336)
Gain on derivatives 3,574 17,012 8,593 7,445
Income on equity method investment 0 328 0 913
Interest income 257 519 987 1,602
Interest expense (3,142) (2,532) (8,805) (6,627)
Other (expense) income, net (22) 2 (19) (1,808)
(Loss) income before income taxes (12,563) 813 (37,448) (49,811)
Income tax expense (28) (138) (350) (260)
Net (loss) income (12,591) 675 (37,798) (50,071)
Other comprehensive income 0 0 0 0
Total comprehensive (loss) income $ (12,591) $ 675 $ (37,798) $ (50,071)
Basic:        
Net income (loss) per share of common stock (in dollars per share) $ (0.66) $ 0.04 $ (2.05) $ (3.00)
Diluted:        
Net income (loss) per share of common stock, diluted (in dollars per share) $ (0.66) $ 0.04 $ (2.05) $ (3.00)
Imagery & software analytical services        
Revenue        
Revenue $ 17,276 $ 15,264 $ 52,578 $ 46,352
Costs and expenses        
Costs excluding depreciation and amortization 3,682 3,479 10,559 10,634
Professional & engineering services        
Revenue        
Revenue 5,273 5,996 19,145 12,632
Costs and expenses        
Costs excluding depreciation and amortization $ 2,968 $ 3,288 $ 10,006 $ 11,137